optinose.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
User-agent: *
Disallow: /wp-admin/
Allow: /wp-admin/admin-ajax.php
Meta Tags
Title Home |
Description Breathing new life intopatient Optinose is a specialty pharmaceutical company focused on creating and bringing to market innovative products for patients with diseases treated by ear, nose, and throat (ENT) and allergy
Keywords N/A
Server Information
WebSite optinose faviconoptinose.com
Host IP 40.71.11.142
Location United States
Related Websites
Site Rank
More to Explore
orchidgardensuites.com
ottawavalley.org
perthinsulation.com
pitusafurniturestore.com
pkonnect.net
pretzels-inc.com
pugetsoundnavymuseum.org
qedenv.com
qkidsacademy.com
quasheba.com
rciperth.com.au
realauthoritymedia.com
revivewellnessgroup.org
royalsubic.com
salinamendoza.com
scinsulation.net.au
scribeph.com
seattlewaeldercare.com
shabihazaidimd.com
stephanieripaphotography.com
optinose.com Valuation
US$16,278,309
Last updated: 2022-06-30 02:27:33

optinose.com has Semrush global rank of 650,209. optinose.com has an estimated worth of US$ 16,278,309, based on its estimated Ads revenue. optinose.com receives approximately 1,878,267 unique visitors each day. Its web server is located in United States, with IP address 40.71.11.142. According to SiteAdvisor, optinose.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$16,278,309
Daily Ads Revenue US$15,027
Monthly Ads Revenue US$450,784
Yearly Ads Revenue US$5,409,408
Daily Unique Visitors 125,218
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
optinose.com. A 3599 IP: 40.71.11.142
optinose.com. NS 86400 NS Record: dns2.cscdns.net.
optinose.com. NS 86400 NS Record: dns1.cscdns.net.
optinose.com. MX 3600 MX Record: 10 optinose-com.mail.protection.outlook.com.
optinose.com. TXT 3600 TXT Record: v=spf1 include:spf.protection.outlook.com -all
optinose.com. TXT 3600 TXT Record: MS=ms32668189
optinose.com. TXT 3600 TXT Record: adobe-idp-site-verification=838a4f47f59bfccb10950fc5cd22ea9025d9eb2c76b062f8a1221b29e57a4b80
optinose.com. TXT 3600 TXT Record: apple-domain-verification=0tWarLuZDEJRL9AN
optinose.com. TXT 3600 TXT Record: docusign=99c5f475-09c4-40e6-95f6-5630e7c21587
HtmlToTextCheckTime:2022-06-30 02:27:33
You are using an outdated browser. Please upgrade your browser to improve your experience. Join Our Team Contact Us Toggle navigation --> Company Our Purpose Company History Leadership Team Board of Directors Partnership Opportunities Corporate Compliance Exhalation Delivery Systems Liquid Delivery Powder Delivery Device Anatomy of the Nasal Passages Nasal Delivery Challenges Therapeutic Areas Products XHANCE ® ONZETRA ® Xsail ® Research & Development XHANCE ® – Future Development Partnerships Investors News & Events Stock Information Corporate Governance SEC Filings Investor Resources News & Media Scientific Communications Peer-Reviewed Journal Publications --> INNOVATIVE TREATMENTS FOR PATIENTS WITH DISEASES CARED FOR BY ENT AND ALLERGY SPECIALISTS Breathing new life into patient care. We Are a Company With a Clear Vision Optinose is a specialty pharmaceutical company focused on creating and bringing to market innovative products for patients with diseases treated by ear,
HTTP Headers
HTTP/1.1 301 Moved Permanently
Content-Length: 0
Content-Type: text/html; charset=UTF-8
Location: https://optinose.com/
Date: Tue, 26 Oct 2021 22:19:41 GMT

HTTP/1.1 301 Moved Permanently
Content-Length: 0
Content-Type: text/html; charset=UTF-8
Location: https://www.optinose.com/
Server: Microsoft-IIS/10.0
X-Powered-By: PHP/7.3.27
X-Redirect-By: WordPress
X-Powered-By: ASP.NET
Set-Cookie: ARRAffinity=1c78c400fa4008b653d1a97806c414fdf5b270a99e81ecee57e6f9db2b830412;Path=/;HttpOnly;Secure;Domain=optinose.com
Set-Cookie: ARRAffinitySameSite=1c78c400fa4008b653d1a97806c414fdf5b270a99e81ecee57e6f9db2b830412;Path=/;HttpOnly;SameSite=None;Secure;Domain=optinose.com
Date: Tue, 26 Oct 2021 22:19:41 GMT

HTTP/1.1 200 OK
Content-Length: 0
Content-Type: text/html; charset=UTF-8
Server: Microsoft-IIS/10.0
X-Powered-By: PHP/7.3.27
Link: ; rel="https://api.w.org/"
Link: ; rel="alternate"; type="application/json"
Link: ; rel=shortlink
X-Powered-By: ASP.NET
Set-Cookie: ARRAffinity=1c78c400fa4008b653d1a97806c414fdf5b270a99e81ecee57e6f9db2b830412;Path=/;HttpOnly;Secure;Domain=www.optinose.com
Set-Cookie: ARRAffinitySameSite=1c78c400fa4008b653d1a97806c414fdf5b270a99e81ecee57e6f9db2b830412;Path=/;HttpOnly;SameSite=None;Secure;Domain=www.optinose.com
Date: Tue, 26 Oct 2021 22:19:42 GMT
optinose.com Whois Information
Domain Name: OPTINOSE.COM
Registry Domain ID: 93849449_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.corporatedomains.com
Registrar URL: http://cscdbs.com
Updated Date: 2021-01-06T06:14:50Z
Creation Date: 2003-01-10T09:22:09Z
Registry Expiry Date: 2022-01-10T09:22:09Z
Registrar: CSC Corporate Domains, Inc.
Registrar IANA ID: 299
Registrar Abuse Contact Email: domainabuse@cscglobal.com
Registrar Abuse Contact Phone: 8887802723
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: serverDeleteProhibited https://icann.org/epp#serverDeleteProhibited
Domain Status: serverTransferProhibited https://icann.org/epp#serverTransferProhibited
Domain Status: serverUpdateProhibited https://icann.org/epp#serverUpdateProhibited
Name Server: DNS1.CSCDNS.NET
Name Server: DNS2.CSCDNS.NET
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-14T21:34:12Z <<<